Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$225.07 - $246.17 $815,428 - $891,873
-3,623 Reduced 6.06%
56,200 $13.1 Million
Q1 2024

May 15, 2024

SELL
$233.45 - $247.73 $5.51 Million - $5.85 Million
-23,605 Reduced 28.29%
59,823 $14.8 Million
Q4 2023

Feb 14, 2024

SELL
$232.24 - $267.23 $25.5 Million - $29.4 Million
-109,997 Reduced 56.87%
83,428 $20.3 Million
Q3 2023

Nov 09, 2023

BUY
$254.9 - $283.59 $1.98 Million - $2.2 Million
7,766 Added 4.18%
193,425 $50 Million
Q2 2023

Aug 11, 2023

BUY
$238.39 - $265.32 $14.5 Million - $16.2 Million
60,904 Added 48.82%
185,659 $49 Million
Q1 2023

May 15, 2023

BUY
$229.71 - $259.35 $25.5 Million - $28.8 Million
111,056 Added 810.69%
124,755 $30.9 Million
Q2 2022

Aug 15, 2022

SELL
$234.74 - $275.42 $60,562 - $71,058
-258 Reduced 1.85%
13,699 $3.38 Million
Q1 2022

May 13, 2022

SELL
$243.64 - $270.48 $189,551 - $210,433
-778 Reduced 5.28%
13,957 $3.62 Million
Q4 2021

Feb 14, 2022

BUY
$230.08 - $250.94 $114,809 - $125,219
499 Added 3.51%
14,735 $3.62 Million
Q3 2021

Nov 03, 2021

SELL
$232.72 - $256.47 $228,298 - $251,597
-981 Reduced 6.45%
14,236 $3.41 Million
Q2 2021

Aug 12, 2021

BUY
$232.65 - $254.58 $91,431 - $100,049
393 Added 2.65%
15,217 $3.61 Million
Q1 2021

May 13, 2021

BUY
$232.09 - $256.88 $308,215 - $341,136
1,328 Added 9.84%
14,824 $3.52 Million
Q4 2020

Feb 12, 2021

SELL
$221.92 - $245.94 $725,900 - $804,469
-3,271 Reduced 19.51%
13,496 $3.29 Million
Q3 2020

Nov 13, 2020

SELL
$215.77 - $276.76 $506,412 - $649,555
-2,347 Reduced 12.28%
16,767 $3.81 Million
Q2 2020

Aug 14, 2020

SELL
$219.9 - $263.41 $90,159 - $107,998
-410 Reduced 2.1%
19,114 $4.46 Million
Q1 2020

May 14, 2020

SELL
$195.69 - $279.01 $49,509 - $70,589
-253 Reduced 1.28%
19,524 $4.38 Million
Q4 2019

Feb 11, 2020

SELL
$236.45 - $266.82 $255,602 - $288,432
-1,081 Reduced 5.18%
19,777 $5.25 Million
Q3 2019

Nov 12, 2019

SELL
$230.58 - $256.08 $60,181 - $66,836
-261 Reduced 1.24%
20,858 $5.15 Million
Q2 2019

Aug 14, 2019

BUY
$217.4 - $246.08 $599,589 - $678,688
2,758 Added 15.02%
21,119 $0
Q1 2019

May 15, 2019

BUY
$206.05 - $248.17 $4,121 - $4,963
20 Added 0.11%
18,361 $0
Q4 2018

Feb 15, 2019

SELL
$204.73 - $257.93 $36,851 - $46,427
-180 Reduced 0.97%
18,341 $4.03 Million
Q3 2018

Nov 14, 2018

SELL
$233.07 - $256.0 $3,262 - $3,584
-14 Reduced 0.08%
18,521 $0
Q2 2018

Aug 08, 2018

BUY
$208.1 - $233.85 $1.95 Million - $2.19 Million
9,382 Added 102.5%
18,535 $0
Q1 2018

May 16, 2018

SELL
$205.46 - $240.27 $17,669 - $20,663
-86 Reduced 0.93%
9,153 $0
Q4 2017

Feb 15, 2018

BUY
$189.0 - $222.64 $745,983 - $878,760
3,947 Added 74.58%
9,239 $0
Q3 2017

Nov 14, 2017

BUY
$186.89 - $198.9 $989,021 - $1.05 Million
5,292
5,292 $0

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $63.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Segall Bryant & Hamill, LLC Portfolio

Follow Segall Bryant & Hamill, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.